Alpha Growth PLC Result of AGM (0735D)

TIDMALGW

RNS Number : 0735D

Alpha Growth PLC

19 June 2023

Alpha Growth plc

(" Alpha " or the "Company")

Result of Annual General Meeting

Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services specialist in the growing longevity asset class and insurance linked asset management, announces that all resolu ti ons proposed at its Annual General Mee ti ng, held 16 June 2023, were duly passed.

At the meeting, all Directors were present to conduct the meeting and took questions from the attending shareholders. The Directors wish to thank the supportive shareholders who attended the in-person meeting for their attendance and con ti nued support.

For more information, please visit www.algwplc.com or contact the following:

 
                                                                            [phone] 
                Alpha Growth plc                                             8600 
                Gobind Sahney, Executive Chairman                           [e-mail] 
                                                                            [phone] 
                  Allenby Capital Limited                                    5656 
                Amrit Nahal (Sales and Corporate Broking) 
                Nick Athanas / Piers Shimwell (Corporate 
                 Finance) 
 
                  UK Investor Relations - Mark Treharne                     [e-mail] 
 

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

***END***

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGEALKPFDLDEFA

(END) Dow Jones Newswires

June 19, 2023 02:00 ET (06:00 GMT)